VIENNA, AUSTRIA, OCTOBER 10, 2010 – GE Healthcare, a unit of General Electric Company (NYSE:GE) and Advanced Cyclotron Systems, Inc. (ACSI), a world leader in the design and manufacturing of cyclotron equipment, announced today their Memorandum of Understanding (MOU) to explore opportunities for collaboration on High Energy (24 and 30 MeV) cyclotrons and related equipment, during this year’s European Association of Nuclear Medicine Congress (EANM) being held in Vienna, Austria.
Vancouver, BC Canada – (October 4, 2010) – Advanced Cyclotron Systems Inc. (ACSI) a leading provider of cyclotron solutions, announced that it has sold a TR24 high current, state-of-the art cyclotron and related equipment to be installed and commissioned at Burnzyan Federal Medical and Biophysical Center (FMBC), in Moscow, Russia.
Vancouver, BC Canada – (October 4, 2010) – Advanced Cyclotron Systems Inc. (ACSI) a leading provider of cyclotron solutions, announced that it has sold a TR19 variable energy (14 – 19 MeV) cyclotron to Horia Hulubei National Institute of Physics and Nuclear Engineering (IFIN-HH), Magurele-Ilfov, Romania.
Vancouver, BC Canada – (September 27, 2010) – Advanced Cyclotron Systems Inc. (ACSI) a leading provider of cyclotron solutions, today announced that it has recently sold a TR24 (a 24 MeV cyclotron) to IPHC (Institut Pluridisciplinaire Hubert Curien) a research unit belonging both to the University of Strasbourg one of the major university of France and CNRS, the National Center for Scientific Research in Alsace, France, one of the largest fundamental research organizations in Europe.
(RICHMOND, B.C.) – A private company is working in partnership with two of Canada’s leading nuclear medicine research centres to develop a solution to the medical isotope crisis for wide spread use.
Advanced Cyclotron Systems Inc. (ACSI) a leading manufacturer of cyclotrons for the production of medical radioisotopes announced today that it has sold two TR-24 cyclotrons to the University of Alberta’s Department of Oncology in Edmonton and the Centre Hospitalier Universitaire de Sherbrooke (CHUS) in Quebec.
(RICHMOND, B.C.) – Research scientists in Sherbrooke and Richmond have published an article in the Journal of Nuclear Medicine documenting clear proof that cyclotrons can be a part of the solution to solving the world’s medical isotope shortage.
Researchers at the CHUS’s Centre de recherche clinique Étienne-Le Bel (CRCELB) and the Université de Sherbrooke, in collaboration with Advanced Cyclotron Systems Inc. in Richmond, have just demonstrated that technetium 99m can be produced using a cyclotron. Diagnostic testing indicates that cyclotron-produced technetium 99m is fully equivalent to that obtained from nuclear reactor, such as the Chalk River facility.
Advanced Cyclotron Systems Inc. (ACSI), a leading provider of cyclotron technology for international Nuclear Medicine Industries, announces the submission of their proposal for a “National Cyclotron Network to Produce Medical Isotopes” to the Government of Canada’s Expert Review Panel on Medical Isotope Production.